Shaanxi Licai Group

Shaanxi Licai Group, primarily through its subsidiary Licai Pharmaceutical Group, is a leading Chinese pharmaceutical enterprise focused on the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. Established in 2003 and headquartered in Xianyang, the company maintains a robust portfolio of over 150 proprietary products, including market leaders like Fukejing Capsules and Bufei Pills. The group operates a sophisticated R&D infrastructure, including the Licai Pharmaceutical Research Institute, which specializes in innovative biological drugs, high-barrier formulations, and chemical APIs. Consistently ranked among China's top 100 TCM enterprises, Shaanxi Licai Group is recognized as the premier pharmaceutical company in the Shaanxi province, integrating a complete industrial chain from drug discovery to commercial sales.